A Primary Care Agenda for Brain Health: A Scientific Statement From the American Heart Association | Stroke
The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease - Hansson - 2022 - Alzheimer's & Dementia - Wiley Online Library
Full article: The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases
Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesis - Liss - 2021 - Journal of Internal Medicine - Wiley Online Library
Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study - The Lancet
Frontiers | Biomarkers in Psychiatry: Concept, Definition, Types and Relevance to the Clinical Reality
Blood Tests for Alzheimer Disease - Practical Neurology
Empowering Physicians to Advance the Future of Alzheimer's Disease - EMJ
Cerebrospinal fluid biomarkers to monitor treatment effects in Alzheimer's disease and related conditions
Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic. - Abstract - Europe PMC
Biomarkers for neurodegenerative diseases | Nature Medicine
Neuroimmune Connections in Aging and Neurodegenerative Diseases: Trends in Immunology
Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay | Molecular Neurodegeneration | Full Text
Recognizing Subtle Signs of Early Stage Neurodegeneration - Holistic Primary Care
Biomarkers for neurodegenerative diseases | Nature Medicine
Frontiers | Re-thinking the Etiological Framework of Neurodegeneration
Medicina | Free Full-Text | Biomarkers for Alzheimer’s Disease: Context of Use, Qualification, and Roadmap for Clinical Implementation
SQSTM1/p62: A Potential Target for Neurodegenerative Disease | ACS Chemical Neuroscience
Biomarkers in vascular dementia: A recent update - ScienceDirect
Medicina | Free Full-Text | Biomarkers for Alzheimer’s Disease: Context of Use, Qualification, and Roadmap for Clinical Implementation
Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic. - Abstract - Europe PMC
Science disconnected: the translational gap between basic science, clinical trials, and patient care in Alzheimer's disease - The Lancet Healthy Longevity
Brain pathological changes during neurodegenerative diseases and their identification methods: How does QSM perform in detecting this process? | Insights into Imaging | Full Text
Physiological changes in neurodegeneration — mechanistic insights and clinical utility | Nature Reviews Neurology
The Role of Amyloid PET in Imaging Neurodegenerative Disorders: A Review | Journal of Nuclear Medicine
Biomarkers of neurodegeneration and glial activation validated in Alzheimer's disease assessed in longitudinal cerebrospinal fluid samples of Parkinson's disease | PLOS ONE
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment: Trends in Pharmacological Sciences
Biomarker Development: A Tool to Prevent Neurodegenerative Disorders | UC Davis Biotechnology Program
